基因页:BCL2L2
概括?
基因ID | 599 |
Symbol | BCL2L2 |
同义词 | bcl-w | bcl2-l-2 | bclw | ppp1r51 |
描述 | BCL2 like 2 |
参考 | MIM:601931|HGNC:HGNC:995|Ensembl:ENSG00000129473|HPRD:03569|Vega:Otthumg0000000028738 |
基因type | protein-coding |
地图位置 | 14q11.2-q12 |
Sherlock P值 | 0.198 |
度p-value | 度:Sanders_2014:DS1_p=0.178:DS1_beta=0.004880:DS2_p=3.17e-05:DS2_beta=0.207:DS2_FDR=1.69e-03 |
Fetal beta | -2.754 |
数据源中的基因
基因set name | 基因组方法 | 描述 | Info |
---|---|---|---|
DEG:Sanders_2013 | Microarray | Whole-genome gene expression profiles using microarrays on lymphoblastoid cell lines (LCLs) from 413 cases and 446 controls. | |
GSMA_I | 基因组扫描荟萃分析 | Psr: 0.047 |
第一节遗传学和表观遗传学注释
Section II. Transcriptome annotation
基因ral gene expression (GTEx)
![无法使用](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/BCL2L2_DE_GTEx.png)
基因expression during devlopment (BrainCloud)
脚注:
总共绘制了269个时间点,n = 38个胎儿样品(x = 1:38)。每个三角形代表一个时间点。
基因expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
基因 | 皮尔逊的相关性 | Spearman's Correlation |
BCAM | 0.60 | 0.72 |
perp | 0.59 | 0.68 |
ZFP36 | 0.59 | 0.49 |
SSH3 | 0.55 | 0.63 |
ICAM1 | 0.54 | 0.58 |
LASS1 | 0.54 | 0.61 |
SLCO4A1 | 0.52 | 0.57 |
FOXF1 | 0.50 | 0.51 |
APOLD1 | 0.49 | 0.36 |
MOBKL2C | 0.49 | 0.56 |
前10个负共表达基因 | ||
基因 | 皮尔逊的相关性 | Spearman's Correlation |
AKT3 | -0.34 | -0.45 |
ZNF33B | -0.33 | -0.45 |
PHF14 | -0.33 | -0.52 |
NLGN1 | -0.33 | -0.40 |
ROBO2 | -0.32 | -0.44 |
EPHA7 | -0.32 | -0.44 |
DOK6 | -0.32 | -0.41 |
ENY2 | -0.32 | -0.40 |
trdmt1 | -0.32 | -0.39 |
FANCM | -0.32 | -0.42 |
Section III. Gene Ontology annotation
Molecular function | 去的术语 | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0005515 | protein binding | 新闻学会 | 15694340|16697956 | |
Biological process | 去的术语 | Evidence | Neuro keywords | PubMed ID |
去:0007283 | 精子发生 | 塔斯 | 8761287 | |
去:0006916 | anti-apoptosis | 塔斯 | 9500547 | |
GO:0042981 | regulation of apoptosis | IEA | - | |
细胞分量 | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0005737 | 细胞质 | NAS | - | |
GO:0005739 | 线粒体 | IEA | - | |
GO:0016020 | 膜 | IEA | - | |
GO:0031966 | mitochondrial membrane | IEA | - |
第四节。蛋白质蛋白相互作用注释
Interactors | Aliases B | Official full name B | Experimental | 资源 | PubMed ID |
---|---|---|---|---|---|
坏的 | BBC2 |BCl2L8 | BCL2-associated agonist of cell death | - | HPRD,Biogrid | 11483855|12115603 |
坏的 | BBC2 |BCl2L8 | BCL2-associated agonist of cell death | 坏与Bcl-w交互。 | BIND | 15694340 |
BAK1 | BAK | BAK-LIKE | BCL2L7 | CDN1 | MGC117255 | MGC3887 | BCL2-antagonist/killer 1 | Affinity Capture-Western | BioGRID | 10381646 |
BAX | BCL2L4 | BCL2-associated X protein | Affinity Capture-Western | BioGRID | 10381646 |
BBC3 | JFY1 | PUMA | BCL2 binding component 3 | Puma interacts with Bcl-w. | BIND | 15694340 |
BCL2L11 | BAM | BIM | BIM-alpha6 | BIM-beta6 | BIM-beta7 | BOD | BimEL | BimL | BCL2-like 11 (apoptosis facilitator) | BIM与Bcl-W相互作用。 | BIND | 15694340 |
BCL2L11 | BAM | BIM | BIM-alpha6 | BIM-beta6 | BIM-beta7 | BOD | BimEL | BimL | BCL2-like 11 (apoptosis facilitator) | 两个杂交 | BioGRID | 9731710 |
BID | FP497 | MGC15319 | MGC42355 | BH3互动域死亡激动剂 | Protein-peptide | BioGRID | 15694340 |
BID | FP497 | MGC15319 | MGC42355 | BH3互动域死亡激动剂 | Bid interacts with Bcl-w. | BIND | 15694340 |
BIK | Bip1 |BP4 |NBK | BCL2-interacting killer (apoptosis-inducing) | Affinity Capture-Western | BioGRID | 10381646 |
BIK | Bip1 |BP4 |NBK | BCL2-interacting killer (apoptosis-inducing) | Bik interacts with Bcl-w. | BIND | 15694340 |
BMF | FLJ00065 | Bcl2 modifying factor | Bmf interacts with Bcl-w. This interaction was modelled on a demonstrated interaction between mouse Bmf and human Bcl-w. | BIND | 15694340 |
BMF | FLJ00065 | Bcl2 modifying factor | - | HPRD,Biogrid | 11546872 |
HRK | DP5 |哈拉基里 | harakiri, BCL2 interacting protein (contains only BH3 domain) | HRK与Bcl-W相互作用。 | BIND | 15694340 |
HRK | DP5 |哈拉基里 | harakiri, BCL2 interacting protein (contains only BH3 domain) | Protein-peptide | BioGRID | 15694340 |
PMAIP1 | APR | NOXA | phorbol-12-myristate-13-acetate-induced protein 1 | Protein-peptide | BioGRID | 15694340 |
PPP1CA | MGC15877 | MGC1674 | PP-1A | PPP1A | protein phosphatase 1, catalytic subunit, alpha isoform | Affinity Capture-Western Reconstituted Complex |
BioGRID | 12115603 |
V.途径注释
Pathway name | Pathway size | #szgr 2.0基因 | Info |
---|---|---|---|
PID P53下游途径 | 137 | 94 | 该途径中的所有SZGR 2.0基因 |
LIU SOX4 TARGETS DN | 309 | 191 | 该途径中的所有SZGR 2.0基因 |
血清剥夺的Graessmann凋亡 | 552 | 347 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN APOPTOSIS BY SERUM DEPRIVATION DN | 234 | 147 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN RESPONSE TO MC AND SERUM DEPRIVATION DN | 84 | 54 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN APOPTOSIS BY DOXORUBICIN UP | 1142 | 669 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781年 | 1082 | 该途径中的所有SZGR 2.0基因 |
GRAESSMANN RESPONSE TO MC AND DOXORUBICIN DN | 770 | 415 | 该途径中的所有SZGR 2.0基因 |
GALLUZZI PREVENT MITOCHONDIAL PERMEABILIZATION | 22 | 16 | 该途径中的所有SZGR 2.0基因 |
AMUNDSON RESPONSE TO ARSENITE | 217 | 143 | 该途径中的所有SZGR 2.0基因 |
KREPPEL CD99 TARGETS DN | 8 | 5 | 该途径中的所有SZGR 2.0基因 |
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | 584 | 395 | 该途径中的所有SZGR 2.0基因 |
TENEDINI MEGAKARYOCYTE MARKERS | 66 | 48 | 该途径中的所有SZGR 2.0基因 |
NATSUME RESPONSE TO INTERFERON BETA UP | 71 | 49 | 该途径中的所有SZGR 2.0基因 |
葡萄病毒感染的Debiasi凋亡 | 314 | 201 | 该途径中的所有SZGR 2.0基因 |
KAYO AGING MUSCLE DN | 123 | 76 | 该途径中的所有SZGR 2.0基因 |
伽马和紫外线辐射受kyng DNA损伤 | 88 | 65 | 该途径中的所有SZGR 2.0基因 |
KYNG DNA DAMAGE UP | 226 | 164 | 该途径中的所有SZGR 2.0基因 |
EHLERS ANEUPLOIDY UP | 41 | 29 | 该途径中的所有SZGR 2.0基因 |
Matzuk胚胎生殖细胞 | 19 | 16 | 该途径中的所有SZGR 2.0基因 |
Matzuk男性繁殖Sertoli | 28 | 23 | 该途径中的所有SZGR 2.0基因 |
MATZUK SPERMATOCYTE | 72 | 55 | 该途径中的所有SZGR 2.0基因 |
MATZUK SPERMATID DIFFERENTIATION | 37 | 26 | 该途径中的所有SZGR 2.0基因 |
BONCI TARGETS OF MIR15A AND MIR16 1 | 91 | 75 | 该途径中的所有SZGR 2.0基因 |
WINTER HYPOXIA METAGENE | 242 | 168 | 该途径中的所有SZGR 2.0基因 |
Beier神经胶质瘤干细胞DN | 66 | 42 | 该途径中的所有SZGR 2.0基因 |
SHAFFER IRF4 TARGETS IN MYELOMA VS MATURE B LYMPHOCYTE | 101 | 76 | 该途径中的所有SZGR 2.0基因 |
肌肉中的罗马胰岛素靶标 | 442 | 263 | 该途径中的所有SZGR 2.0基因 |
YAGI AML WITH INV 16 TRANSLOCATION | 422 | 277 | 该途径中的所有SZGR 2.0基因 |
MIKKELSEN ES ICP WITH H3K4ME3 | 718 | 401 | 该途径中的所有SZGR 2.0基因 |
Mikkelsen NPC ICP带有H3K4Me3 | 445 | 257 | 该途径中的所有SZGR 2.0基因 |
金双相情感障碍少突胶质细胞密度相关 | 682 | 440 | 该途径中的所有SZGR 2.0基因 |
ZWANG TRANSIENTLY UP BY 2ND EGF PULSE ONLY | 1725年 | 838 | 该途径中的所有SZGR 2.0基因 |
Section VI. microRNA annotation
miRNA family | 目标位置 | mirna id | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
mir-10 | 1902 | 1908 | 1A | HSA-MIR-10A | uacccuguagauccgaauuugug |
HSA-MIR-10B | UACCCUGUAGAACCGAAUUUGU | ||||
mir-103/107 | 1364 | 1370 | 1A | HSA-MIR-103脑 | AGCAGCAUUGUACAGGGCUAUGA |
HSA-MIR-107脑 | agcagcauuguacgggcuauca | ||||
mir-122 | 1331 | 1337 | 1A | hsa-miR-122a | UGGAGUGUGACAAUGGUGUUUGU |
mir-133 | 1544年 | 1551年 | 1A,m8 | hsa-miR-133a | UUGGUCCCCUUCAACCAGCUGU |
hsa-miR-133b | UUGGUCCCCUUCAACCAGCUA | ||||
mir-140 | 1954年 | 1960年 | m8 | hsa-miR-140脑 | agugguuuuacccuaugguag |
miR-148/152 | 1450 | 1456 | 1A | hsa-miR-148a | UCAGUGCACUACAGAACUUUGU |
hsa-miR-152脑 | UCAGUGCAUGACAGAACUUGGG | ||||
hsa-miR-148b | UCAGUGCAUCACAGAACUUUGU | ||||
mir-149 | 1350 | 1357 | 1A,m8 | hsa-miR-149脑 | UCUGGCUCCGUGUCUUCACUCC |
mir-15/16/195/424/497 | 1390 | 1396 | m8 | hsa-miR-15a脑 | UAGCAGCACAUAAUGGUUUGUG |
HSA-MIR-16脑 | uagcagcacguaaauauuggcg | ||||
hsa-miR-15b脑 | uagcagcacaucaugguuaca | ||||
hsa-miR-195SZ | UAGCAGCACAGAAAUAUUGGC | ||||
HSA-MIR-424 | Cagcagcaauucauguuuugaa | ||||
hsa-miR-497 | CAGCAGCACACUGUGGUUUGU | ||||
hsa-miR-15a脑 | UAGCAGCACAUAAUGGUUUGUG | ||||
HSA-MIR-16脑 | uagcagcacguaaauauuggcg | ||||
hsa-miR-15b脑 | uagcagcacaucaugguuaca | ||||
hsa-miR-195SZ | UAGCAGCACAGAAAUAUUGGC | ||||
HSA-MIR-424 | Cagcagcaauucauguuuugaa | ||||
hsa-miR-497 | CAGCAGCACACUGUGGUUUGU | ||||
mir-17-5p/20/93.mr/106/519.D | 1599 | 1605 | m8 | hsa-miR-17-5p | CAAAGUGCUUACAGUGCAGGUAGU |
HSA-MIR-20A脑 | uaaagugcuuauagugcagguag | ||||
HSA-MIR-106A | aaaagugcuuacugugcagguagc | ||||
HSA-MIR-106BSZ | uaaagugcugacagugcagau | ||||
HSA-MIR-20BSZ | CAAAGUGCUCAUAGUGCAGGUAG | ||||
hsa-miR-519d | CAAAGUGCCUCCCUUUAGAGUGU | ||||
miR-214 | 1935年 | 1941年 | 1A | HSA-MIR-214脑 | ACAGCAGGCACAGACAGGCAG |
mir-24 | 1348 | 1355 | 1A,m8 | HSA-MIR-24SZ | UGGCUCAGUUCAGCAGGAACAG |
mir-29 | 1379 | 1385 | 1A | hsa-miR-29aSZ | uagcaccaucugaaaucgguu |
hsa-miR-29bSZ | uagcaccauuugaaaucaguguu | ||||
hsa-miR-29cSZ | UAGCACCAUUUGAAAUCGGU | ||||
miR-30-3p | 1938 | 1944年 | 1A | hsa-miR-30a-3p | cuuucagucggauguugcagc |
hsa-miR-30e-3p | CUUUCAGUCGGAUGUUUACAGC |